Neuromodulation device
The invention provides devices, apparatuses, systems and methods for treating and ameliorating inflammation of the gut. In particular, the invention provides devices, apparatuses and methods in which a neuromodulatory signal is delivered a splenic nerve and/or superior mesenteric plexus (SMP). The signal is able to treat inflammatory disorders, e.g., colitis, for example in Inflammatory Bowel Disease.
1. An apparatus or system for modulating the neural activity of the superior mesenteric plexus (SMP) of a patient, the apparatus or system comprising:
a first transducer comprising a cuff electrode configured to encompass the SMP and the superior mesenteric artery, the first transducer configured to apply a first electrical stimulatory signal to the SMP; and
a controller coupled to the first transducer, the controller controlling the first electrical stimulatory signal to be applied by the first transducer, such that the first electrical stimulatory signal increases the neural activity of a nerve to which it is applied to produce an increase in local sympathetic tone in the spleen and/or gut of the subject.
2. An apparatus or system for treating an inflammatory disorder in a patient, the apparatus or system comprising:
a first transducer comprising a cuff electrode configured to encompass the SMP and the superior mesenteric artery, the first transducer configured to apply a first electrical stimulatory signal to the superior mesenteric plexus (SMP) of the patient; and
a controller coupled to the first transducer, the controller controlling the first electrical stimulatory signal to be applied by the first transducer, such that the first electrical stimulatory signal increases the neural activity of a nerve to which it is applied to produce an increase in local sympathetic tone in the spleen and/or gut of the patient.
3. An apparatus or system according to claim 1 , wherein the increase in local sympathetic tone comprises an increase in gut (intestine and/or colon) tissue and/or circulating nor-epinephrine.
4. An apparatus or system according to claim 1 , wherein the controller is coupled to a detector element to detect one or more physiological parameters in the patient, and the controller causes the first transducer to apply the first electrical stimulatory signal when the physiological parameter is detected to be meeting or exceeding a predefined threshold value, wherein one or more of the detected physiological parameters is selected from: sympathetic tone; gut tissue and/or circulating nor-epinephrine (NE) levels; gut tissue and/or circulating substance P levels; gut tissue and/or circulating levels of one or more inflammatory markers.
5. An apparatus or system according to claim 1 , wherein the apparatus or system is suitable for at least partial implantation into the patient, optionally full implantation into the patient.
6. A method of treating colitis in a patient comprising:
i. implanting in the patient an apparatus or system according to claim 1 ;
ii. positioning the cuff electrode around and in signalling contact with the SMP and the superior mesenteric artery of the patient;
iii. activating the apparatus or system to apply the first electrical stimulatory signal to the SMP;
thereby modulating neural activity of the splenic nerve and/or SMP of the patient.
7. A method according to claim 6 , further comprising:
positioning a second transducer in signalling contact with the splenic nerve of the patient; and
activating the apparatus or system to apply a second stimulatory signal to the splenic nerve, thereby modulating neural activity of the splenic nerve.
8. A method according to claim 6 , wherein at least one device or apparatus comprising the first transducer is at least partially implanted in the patient, optionally wholly implanted in the patient.
9. A method according to claim 6 , wherein treatment of the colitis is indicated by an increase in local sympathetic tone in the spleen and/or gut.
10. A method according to claim 6 , wherein the increase in local sympathetic tone comprises an increase in gut tissue and/or circulating nor-epinephrine.
11. A method according to claim 6 , wherein the first stimulatory signal is applied intermittently.
12. A method according to claim 6 , further comprising the step of detecting one or more physiological parameters in the patient, wherein the first electrical stimulatory signal is applied only when the detected physiological parameter meets or exceeds a predefined threshold value, wherein one or more detected physiological parameters is selected from: sympathetic tone; gut tissue and/or circulating nor-epinephrine (NE) levels; gut tissue and/or circulating substance P levels; gut tissue and/or circulating levels of one or more inflammatory markers.
13. An apparatus or system of claim 1 , wherein the first electrical stimulatory signal comprises an alternative current (AC) waveform.
14. An apparatus or system of claim 1 , further comprising:
a second transducer configured to apply a second stimulatory signal to the splenic nerve, wherein the controller is further coupled to the second transducer, the controller controlling the second stimulatory signal to be applied by the second transducer, such that the second stimulatory signal increases the neural activity of a nerve to which it is applied to produce an increase in local sympathetic tone in the spleen.
15. An apparatus or system of claim 14 , wherein the first electrical stimulatory signal and the second stimulatory signal applied by the first transducer and the second transducer, respectively, are independently selected.